Munich, Germany

Lutz G Gürtler

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dade Behring Marburg Gmbh. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lutz G Gürtler. Retrieved from https://idiyas.com/inventor/lutz-g-gürtler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lutz G Gürtler: Innovator in HIV Research

Introduction

Lutz G Gürtler is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunodeficiency research, particularly concerning HIV. His work has led to advancements in understanding and detecting retroviruses associated with immunodeficiency diseases.

Latest Patents

Gürtler holds a patent for a novel HIV type O immunodeficiency virus designated MVP-2901/94. This patent discloses a retrovirus that has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 950121601. The patent also details the characteristic antigens that can be obtained from the virus, which are essential for detecting antibodies against retroviruses linked to immunodeficiency diseases. Additionally, it includes partial DNA and amino acid sequences of the virus.

Career Highlights

Lutz G Gürtler is associated with Dade Behring Marburg GmbH, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of HIV and its implications for public health.

Collaborations

Gürtler has collaborated with notable colleagues such as Hans-Peter Hauser and Stefan Knapp. These collaborations have further enriched his research and contributed to the scientific community's understanding of retroviruses.

Conclusion

Lutz G Gürtler's innovative work in HIV research exemplifies the importance of scientific inquiry in addressing global health challenges. His contributions continue to influence the field and pave the way for future advancements in immunodeficiency research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…